参与实用性透析试验的意愿:医生决策自主权与知情同意方式的重要性
该研究采用离散选择实验与联合分析,调查200例门诊血液透析患者和203名肾脏科医生对实用性透析试验中医生治疗自主权、研究负担和知情同意方式的偏好。结果显示,医生自主权高低和研究负担大小对患者及医生的参与意愿均无显著影响;但知情同意方式显著影响接受度,患者和医生均更偏好至少包含某种形式患者通知的同意方式,不过多数患者仍愿意参与不通知患者的研究。
要点
- 医生自主权高低和研究负担大小对患者及医生的试验参与意愿均无显著影响。
- 患者和医生均更偏好至少包含某种形式患者通知的知情同意方式。
- 多数患者仍愿意参与不通知患者的研究,但比例低于其他同意方式。
核心结论
- 削减医生治疗自主权和增加参与相关负担并未影响患者或医生参与假设性研究的意愿,提示实用性透析试验总体上可为患者和医生所接受。
- 患者和医生均偏好至少包含某种程度患者通知的知情同意方式,但多数患者仍愿意参与不通知患者的研究。
研究设计与样本
- 离散选择实验,采用联合分析评估实用性透析试验特定属性对患者和医生参与意愿的影响。
- 电子调查数据来自11个门诊血液透析单位的200例患者和203名肾脏科医生。
- 研究的三个属性为医生治疗自主权、参与者研究负担和知情同意方式,采用混合效应逻辑回归量化各属性的影响。
主要发现
- 患者愿意让其设施参与高医生自主权与低医生自主权试验的比例相似(77% vs 79%;p=0.13)。
- 患者愿意让其设施参与高研究负担与低研究负担试验的比例相似(76% vs 80%;p=0.06)。
- 选择加入、选择退出和仅通知三种同意方式可被多数患者接受(分别为84%、82%和81%),但相比每种方式,愿意参与不通知研究的患者较少(66%)(每种两两比较p<0.001)。
- 医生愿意参与高医生自主权与低医生自主权试验的比例相似(61% vs 61%;p=0.96),愿意参与低负担与高负担试验的比例相似(60% vs 61%;p=0.79)。
- 医生愿意参与选择加入、选择退出和仅通知同意方式试验的比例分别为77%、69%和62%,愿意参与不通知试验的比例为36%(每种两两比较p<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pragmatic clinical trials embedded in routine delivery of clinical care can lead to improvements in quality of care, but often have design features that raise ethical concerns. METHODS: We performed a discrete choice experiment and used conjoint analysis to assess how specific attributes of pragmatic dialysis trials influenced patients' and physicians' willingness to have their dialysis facility participate in a hypothetical trial of hypertension management. Electronic survey data were collected from 200 patients enrolled from 11 outpatient hemodialysis units and from 203 nephrologists. The three attributes studied were physicians' treatment autonomy, participants' research burden, and the approach to consent. The influence of each attribute was quantified using mixed-effects logistic regression. RESULTS: Similar proportions of patients were willing to have their facilities participate in a trial with high vs. low physician autonomy (77% vs. 79%; p = 0.13) and research burden (76% vs. 80%; p = 0.06). Opt-in, opt-out, and notification-only consent approaches were acceptable to most patients (84%, 82%, and 81%, respectively), but compared to each of these consent approaches, fewer patients (66%) were willing to have their facility participate in a trial that used no notification (p < 0.001 for each 2-way comparison). Among the physicians, similar proportions were willing to participate in trials with high and low physician autonomy (61% and 61%, respectively, p = 0.96) or with low and high burden (60 and 61%, respectively, p = 0.79). However, as for the patients, the consent approach influenced trial acceptability with 77%, 69%, and 62% willing to participate using opt-in, opt-out, and notification-only, respectively, compared to no notification (36%) (p < 0.001 for each 2-way comparison). CONCLUSIONS: Curtailing physician's treatment autonomy and increasing the burden associated with participation did not influence patients' or physicians' willingness to participate in the hypothetical research, suggesting that pragmatic dialysis trials are generally acceptable to patients and physicians. Both patients and physicians preferred consent approaches that include at least some level of patient notification, but the majority of patients were still willing to participate in trials that did not notify patients of the research.
引用
- Courtright KR, Halpern SD, Joffe S, et al. Willingness to participate in pragmatic dialysis trials: the importance of physician decisional autonomy and consent approach. Trials. 2017. PMID: 29020994. doi:10.1186/s13063-017-2217-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。